Obesity Treatment Market Overview:
Market Research Future (MRFR), while discussing the possibilities of the global obesity treatment market size is predicted rise by 16.7% during the forecast period of 2018 to 2023. This growth will depend a lot on the changes in weight loss and weight management market.
The obesity treatment market size will depend on aspects like the rising awareness, a surge in the number of health-conscious people, better inclusion rate for latest technologies, a hike in investment for research and development, innovations and their speedy approval, awaiting products in the pipeline, a surge in disposable income, changing food habits, and others. In developing countries, this growth is getting backed by strategies launched by top brands to ensure their expansion.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5872
However, the obesity treatment market share may find some roadblocks in the form of a sedentary lifestyle that has been enforced on people by rapidly increasing industrialization and urbanization.
Obesity Treatment Market Segmentation:
The global obesity treatment market has been studied by MRFR on the basis of a type, diagnosis, treatment, and end-user. These segments and data in them are expected to facilitate the decision-making process for the future.
By type, the obesity treatment market has been studied on the basis of food obesity, anxiety obesity, inactivity obesity, atherogenic obesity, venous obesity, and gluten obesity.
By diagnosis, the report containing details of the obesity treatment market has been segmented into physical examination, blood tests, and others. The blood tests segment includes thyroid test, liver function test, cholesterol test, and others. The physical examination segment comprises blood pressure measurement, heart rate measurement, and others.
By treatment, the study on the global obesity treatment market includes surgery, medication, lifestyle changes, and others. The medication segment has been studied on the basis of lorcaserin, orlistat, liraglutide, phentermine and topiramate, and others. The surgery segment includes Laparoscopic Adjustable Gastric Banding (LAGB), gastric bypass surgery, biliopancreatic diversion, gastric sleeve, gastric sleeve, and others.
By end-user, the report on the obesity treatment market includes clinics, pharmacies, hospitals, and others.
Obesity Treatment Market Regional Analysis:
The Americas is slated to take the lead of the global market during the forecast period by maintaining a steady flow of investment, increasing awareness, and funding various research projects. The US and Canada would impact the market the most. In Asia Pacific, the growth would experience traction from rising disposable income.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/obesity-treatment-market-5872
Obesity Treatment Market Competitive Landscape:
Arena Pharmaceuticals, Inc. (U.S.), VIVUS, Inc. (U.S.), Novo Nordisk A/S (Denmark), Orexigen Therapeutics, Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), Cousin Biotech (France), EnteroMedics, Inc. (U.S.), Allergan (Republic of Ireland), Olympus Corporation (Japan), Medtronic (U.S.), USGI Medical, Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Covidien plc (Republic of Ireland), Mediflex Surgical Products (U.S.), and others are some of the major companies impacting the obesity treatment market trends and outcomes.
Obesity Treatment Industry News:
Pennington Biomedical Research Center in Baton Rouge, LA, declared that they had discovered BAM15. This is a protein that can have a significant impact on the potential treatment for obesity and it can help in curbing the impact of related diseases. BAM15 increases mitochondrial respiration and other sustained activity in major ways, it does not impact food consumption but reduces the influence of mitochondria.
Novo Nordisk declared the results of two clinical trials with a phase 2 monotherapy trial and a phase 1 combination trial of AM833, a novel once-weekly subcutaneous amylin analogue (AM833), and once-weekly subcutaneous semaglutide 2.4 mg. This test was conducted to understand obesity or overweight that have at least one weight-related comorbidity.
Browse More Healthcare Research Reports at:
• Healthcare Business Intelligence Market size in 2017 was valued at USD 3,650.1 million and is likely to grow at at a 15.5% CAGR By 2023
• Animal Health Market size is expected to grow at a strong 5.7% CAGR over the forecast period
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/obesity-treatment-market-5872